Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP9AB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,874
Award facts
- Contract value 100% obligated
- $49,874.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,874.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 milligram per 2 milliliter Dupixent pens on January 29, 2026, with a completion date of January 30, 2026. This competitively awarded, non-set-aside contract is for delivery of the pharmaceutical product to the agency's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor specializing in federal medical procurement and serves as a critical vendor for military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. Dupixent, a biologic treatment used for conditions including moderate-to-severe atopic dermatitis and certain asthma presentations, represents part of the specialized pharmaceutical portfolio available through this contract vehicle to serve the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FP9AB?
SPE2DR26FP9AB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FP9AB worth?
The government has obligated $49,874 on SPE2DR26FP9AB.
Is contract SPE2DR26FP9AB an order under another contract?
Yes. SPE2DR26FP9AB is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP9AB competed?
The extent of competition for SPE2DR26FP9AB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award